As a biomarker, serum albumin (Alb) can not only reflect the nutritional status of the body but also remove pro-inflammatory stimulating factors in the body and relieve inflammatory reactions, indicating the level of systemic inflammatory status to a certain extent, which has a certain value in evaluating the prognosis of patients with NSCLC. This evidence concerns the gene ALB and non-small cell lung carcinoma.